Intervention not reported
Treatment related mortality · People with limited‐stage small‐cell lung cancer
1 finding from 1 review
Intervention not reported
Hospital or 30‐day mortality
It is very uncertain whether the intervention changes hospital or 30‐day mortality (very low certainty).
1 finding from 1 review
All‐cause mortality (nerves)
1 finding from 1 review
Mortality (Hospital or 28‐day) · surgical patients
Protocol to increase global blood flow showed no clear difference in mortality (Hospital or 28‐day) compared with control (low certainty).
1 finding from 1 review
Intervention not reported
Long‐term mortality (> 36 months) · patients with diffuse emphysema
The intervention probably leads to lower long‐term mortality (> 36 months) (moderate certainty).
1 finding from 1 review
Overall survival: mortality at 5 years · breast‐conserving radiotherapy for breast cancer
Boost showed no clear difference in overall survival: mortality at 5 years compared with no boost (moderate certainty).
1 finding from 1 review
Mortality (up to 90 days) ‐ not reported · obstetric surgeries
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (up to 90 days) ‐ not reported · orthopaedic (knee)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (up to 90 days) ‐ not reported · orthopaedic (spinal)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality/survival (> 30 days) · People undergoing elective abdominal aortic aneurysm repair
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality (death from any cause)
The intervention showed no clear difference in all‐cause mortality (death from any cause) (high certainty).
1 finding from 1 review
Disease-free survival (new disease, progression or mortality) · breast‐conserving radiotherapy for breast cancer
Boost showed no clear difference in disease‐free survival: disease progression/mortality at 5 years compared with no boost (low certainty).
1 finding from 1 review